Levaletrrol ( Letrozole) 2.5 mg

Name Lemara
Description

Lemara tablets contain an active substance called letrozole. It belongs to a group of medicines called

aromatase inhibitors. It is a hormonal (or “endocrine”) breast cancer treatment. Growth of breast cancer

is frequently stimulated by oestrogens which are female sex hormones. Lemara reduces the amount of

oestrogen by blocking an enzyme (“aromatase”) involved in the production of oestrogens and therefore

may block the growth of breast cancer that needs oestrogens to grow. As a consequence, tumour cells

slow or stop growing and/or spreading to other parts of the body.

Active Ingredient Letrozole
Indication
  • Adjuvant treatment of postmenopausal women with hormone receptor positive invasive early breast cancer.
  • Extended adjuvant treatment of hormone-dependent invasive breast cancer in postmenopausal women who have received prior standard adjuvant tamoxifen therapy for 5 years.
  • First-line treatment in postmenopausal women with hormone-dependent advanced breast cancer.
  • Advanced breast cancer after relapse or disease progression, in women with natural or artificially induced postmenopausal endocrine status, who have previously been treated with anti-oestrogens.
  • Neo-adjuvant treatment of postmenopausal women with hormone receptor positive, HER-2 negative breast cancer where chemotherapy is not suitable and immediate surgery not indicated.
Strengths 2.5 mg
Business Partner MYLAN SAS
Origin FRANCE